Role of intrarenal endothelin 1, endothelin 3, and angiotensin II expression in chronic cyclosporin A nephrotoxicity in rats

Experimental Nephrology

Volumn 8, Issue 3, 2000, Pages 161-172

  Ramírez, César ^a   Olmo, Asunción ^a   O'Valle, Francisco ^a   Masseroli, Marco ^a   Aguilar, Mariano ^a   Gómez Morales, Mercedes ^a   Revelles, Francisco ^a   García Chicano, María José ^a   Arrebola, Francisco ^a   Reguero, María Eugenia ^a   Del Moral, Raimundo G ^a,b  

^a University Hospitals   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Angiotensin II; Cyclosporin A; Endothelin 1; Endothelin 3; Nephrotoxicity

Indexed keywords

CYCLOSPORIN A; ENDOTHELIN 1; ENDOTHELIN 3;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NEPHROSCLEROSIS; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT;

EID: 2542510069     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020664     Document Type: Article

References (61)

1. Flanagan WM, Corthesy B, Bram RJ, Crabtree GR: Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporine A. Nature 1991;352:803-807.
2. Jain JN, McCaffrey PG, Miner Z, Kerppola TK, Lambert JN, Verdine GL, Curran T, Rao A: The T-cell transcription factor NFAT(p) is a substrate for calcineurine and interacts with Fos and Jun. Nature 1993;365:352-355.
3. García del Moral R, O'Valle F, Andújar M, Agiular M, Lucena MA, López-Hidalgo J, Ramírez C, Medina-Cano MT, Aguilar D, Gómez-Morales M: Relationship between P-glycoprotein expression and cyclosporin A in kidney: An immunohistological and cell culture study. Am J Pathol 1995;146:398-408.
4. Del Moral RG, Andújar M, Ramírez C, Gómez-Morales M, Masseroli M, Aguilar M, Olmo A, Arrebola F, Guillén M, García-Chicano MJ, Nogales FF, O'Valle F: Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits. Am J Pathol 1997;151:1705-1714.
5. Del Moral RG, Olmo A, Aguilar M, O'Valle F: P-glycoprotein: A new mechanism to control drug-induced nephrotoxicity. Exp Nephrol 1998;6:89-97.
6. Abassi ZA, Pieruzzi F, Nakhoul F, Keiser HR: Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat. Hypertension 1996;27:1140-1148.
7. Shihab FS, Andoh TF, Tanner AM, Noble NA, Border WA, Franceschini N, Bennett WM: Role of transforming growth factor beta-1 in experimental chronic cyclosporine nephropathy. Kidney Int 1996;49:1141-1151.
8. Myers BD: Cyclosporine nephrotoxicity. Kidney Int 1986;30:964-974.
9. Rossi NF, Churchill PC, McDonald FD, Ellis VR: Mechanism of cyclosporin A-induced renal vasoconstriction in the rat. J Pharmacol Exp Ther 1989;250:896-901.
10. Nast C, Adler SG, Artishevsky A, Kresser CT, Ahmed K, Anderson PS: Cyclosporine induces elevated procollagen alpha 1 (I) mRNA levels in the rat renal cortex. Kidney Int 1991;39: 631-638.
11. Racusen LC, Solez K: Nephrotoxicity of cyclosporine and other immunosuppressive and immunotherapeutic agents; in Hook JB, Goldstein RS (eds): Toxicology of the Kidney, ed 2. New York, Raven Press, 1993, pp 319-360.
12. Mihatsch MJ, Antonovych T, Bohman SO, Habib R, Helmchan U, Noel LH, Olsen S, Sibley RK, Kemeny E, Feutren G: Cyclosporin A nephropathy: Standardization of the evaluation of kidney biopsies. Clin Nephrol 1994;41: 23-32.
13. Rosen S, Greenfeld Z, Brezis M: Chronic cyclosporine-induced nephropathy in the rat: A medullary ray and inner stripe injury. Transplantation 1990;49:445-452.
14. Elzinga LW, Rosen S, Bennett WM: Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporinc nephropathy: Role of sodium intake. J Am Soc Nephrol 1993;4:214-221.
15. Burdmann EA, Andoh TF, Nast CC, Evans A, Connors BA, Coffman TM, Lindsley J, Bennett WM: Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 1995;269:F491-F499.
16. Shihab FS, Bennett WM, Tanner AM, Andoh TF: Angiotensin II blockade decreases TGF-beta-1 and matrix proteins in cyclosporine nephropathy. Kidney Int 1997;52:660-673.
17. Kon V, Hunley TE, Fogo A: Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II affects fibrosis: Studies in chronic nephrotoxicity in rats. Transplantation 1995;60:89-95.
18. Young BA, Burdmann EA, Johnson RJ, Alpers CE, Giachelli CM, Eng E, Andoh A, Bennett WM, Couser WG, Lindsley J, Duyn J: Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 1995;48:439-448.
19. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM: Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy. Kidney Int 1996;50:1089-1100.
20. Ehrenreich H, Anderson RW, Fox CH, Riekmann P, Hoffman GS, Travis WD, Coligan JE, Kehrl J, Fauci AS: Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990;172: 1741-1748.
21. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331:1286-1292.
22. Sharma VK, Bologa RM, Xu GP, Li B, Mouradian J, Wang J, Serur D, Rao V, Suthanthiran M: Intragraft TGF-β1 mRNA: A correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int 1996;49:1297-1303.
23. Karet FE, Davenport AP: Localization of endothelin peptides in human kidney. Kidney Int 1996;49:382-387.
24. Murata S, Matsumura Y, Takada K, Asai Y, Takaoka M, Morimoto S: Role of transforming growth factor beta-1 on platelet-induced enhancement of endothelin-1 production in cultured vascular endothelial cells. J Pharmacol Exp Ther 1995;274:1524-1530.
25. Wilkes BM, Pearl AR, Mento PF, Maita ME, Macica CM, Girardi EP: Glomerular endothelin receptors during initiation and maintenance of ischemic acute renal failure in rats. Am J Physiol 1991;260:F110-F118.
26. Haug G, Grill C, Schmid-Kotsas A, Gruenert A, Jehle PM: Endothelin release by rabbit proximal tubule cells: Modulating effects of cyclosporine A, tacrolimus, HGF and EGF. Kidney Int 1998;54:1626-1636.
27. Schnermann J, Lorenz JN, Briggs JP, Keiser JA: Induction of water diuresis by endothelin in rats. Am J Physiol 1992;263:F516-F526.
28. Masseroli M, O'Valle F, Andújar M, Ramírez C, Gómez-Morales M, Luna JD, Aguilar M, Aguilar D, Rodríguez-Puyol M, Del Moral RG: Design and validation of a new image analysis method for automatic quantification of interstitial fibrosis and glomerular morphometry. Lab Invest 1998;78:511-522.
29. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
30. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989.
31. Sakurai T, Yanagisawa M. Inoue A, Ryan US, Kimura S, Mitsui Y, Goto K, Masaki T: cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem Biophys Res Commun 1991;175:44-47.
32. Shiba R, Sakurai T, Yamada G, Morimoto H, Saito A, Masaki T, Goto K: Cloning and expression of rat preproendothelin-3 cDNA. Biochem Biophys Res Commun 1992;186:588-594.
33. Southern EM: Detection of specific genes among DNA fragments separated by gel electrophoresis. J Mol Biol 1975;98:503-517.
34. English J, Evan A, Houghton DC, Bennett WM: Cyclosporine-induced acute renal dysfunction in the rat: Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation 1987;44:135-141.
35. Curtis JJ, Luke RG, Duvosvky E, Diethelm AG, Whelchel JD, Jones P: Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 1986;ii:477-479.
36. 2 receptor antagonists on cyclosporin A renal vasoconstriction. Am J Physiol 1994;267:F443-F449.
37. Shehata M, El Nahas AM, Barkworth E, Cope GH, Raftery AT: Increased platelet-derived growth factor in the kidneys of cyclosporin-treated rats. Kidney Int 1994;46:726-732.
38. 2 formation by rat mesangial cells in culture. Kidney Int 1989;35: 1161-1167.
39. Bobadilla NA, Tapia E, Franco M, López P, Mendoza S, García-Torres R, Alvarado JA, Herrera-Acosta J: Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity. Kidney Int 1994;46:773-779.
40. Young BA, Burdmann EA, Johnson RJ, Andoh T, Bennett WM, Couser WG, Alpers CE: Cyclosporine A induced arteriopathy in a rat model of chronic cyclosporine nephropathy. Kidney Int 1995;48:431-438.
41. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzi P, Floege J, Schwartz SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 1992;19:464-474.
42. Kon V, Hunley TE, Fogo A: Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin-II effects fibrosis: Studies in chronic cyclosporine nephrotoxicity in rats. Transplantation 1995;60:89-95.
43. García del Moral R, Navarro N, Montes A, Aguilar D, Aneiros J: Immunohistochemical markers of renal tubular injury and cyclosporin nephrotoxicity in kidney allograft biopsies. Nephron 1992;62:121-122.
44. Bennett WM: Drug interactions and consequences of sodium restriction. Am J Clin Nutr 1997;65(suppl):678-681.
45. Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, Shankland SJ, Alpers CE, Bennett WM, Couser WG, Johnson RJ: Pathogenesis of cyclosporine nephropathy: Role of angiotensin II and oestopontin. J Am Soc Nephrol 1995;6:1186-1196.
46. Shihab FS, Andoh TF, Tanner AM, Bennett WM: Sodium depletion enhances fibrosis and the expression of TGF-beta-1 and matrix proteins in experimental chronic cyclosporine nephropathy. Am J Kidney Dis 1997;30:71-81.
47. Ros J, Leivas A, Jimenez W, Morales M, Bosh-Marce M, Arroyo V, Rivera F, Rodes J: Effect of bacterial lipopolysaccharideon endothelin-1 production in human vascular endothelial cells. J Hepatol 1997;26:81-87.
48. Bruzzi I, Corna D, Zoja C, Orisio S, Schiffrin EL, Cavallotti D, Remuzzi G, Benigni A: Time course and localization of endothelin-1 gene expression in a model of renal disease progression. Am J Pathol 1997;151:1241-1247.
49. Largo R, Gómez-Garre D, Liu XH, Alonso J, Blanco J, Plaza JJ, Egido J: Endothelin-1 uprcgulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinapril. Hypertension 1997; 29:1178-1185.
50. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F: Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992;19:753-757.
51. Kurihara H, Yoshizumi M, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Hamaoki M, Kato H, Yasaki Y: Transforming growth factor-β stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 1989;159:1435-1440.
52. Abassi ZA, Pieruzzi F, Nakhoul F, Keiser HR: Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat. Hypertension 1996;27:1140-1148.
53. Zoja C, Morigi M, Figliuzzi M, Bruzi I, Oldroyd S, Benigni A, Ronco P, Remuzzi G: Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 1995;26:934-941.
54. Schramek H, Willinger CC, Gstraunthaler G, Pfaller W: Endothelin-3 modulates glomerular filtration rate in the isolated perfused rat kidney. Renal Physiol Biochem 1992;15:325-333.
55. Takeda M, Iwasaki S, Hellings SE, Yoshida H, Homma T, Kon V: Divergent expression of EtA and EtB receptors in response to cyclosporine in mesangial cells. Am J Pathol 1994;144: 473-479.
56. Tack I, Marin Castaño E, Bascands JL, Pecher C, Ader JL, Girolami JP: Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelin B receptor. Br J Pharmacol 1997;121:433-440.
57. Yang CW, Kim YS, Kim J, Kim YO, Min SY, Choi EJ, Bang BK: Oral supplementation of L-arginine prevents chronic cyclosporine nephrotoxicity in rats. Exp Nephrol 1998;6:50-56.
58. Cristol JP, Warner TD, Thiemermann C, Vane JR: Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafbtoxins in the systemic circulation and renal vasculature of the anesthetized rat. Br J Pharmacol 1994;108:7765-7779.
59. Ong ACM, Jowett TP, Firth JD, Burton S, Karet FE, Fine LG: An endothelin-1 mediated autocrine growth loop involved in human renal tubular regeneration. Kidney Int 1995;48:390-401.
60. Wastchinger B. Sayegh MH: Endothelin in organ transplantation. Am J Kidney Dis 1996;27: 151-161.
61. Hermansky SJ, Neptun DA, Loughran KA, Leung HW: Effects of polyethylene glycol 400 (PEG 400) following 13 weeks of gavage treatment in Fisher-344 rats. Food Chem Toxicol 1995;33:139-149.